Quantitative prediction of the impact of drug interactions and genetic polymorphisms on cytochrome P450 2C9 substrate exposure.
about
CYP2C9 genotype vs. metabolic phenotype for individual drug dosing--a correlation analysis using flurbiprofen as probe drugReliability and extension of quantitative prediction of CYP3A4-mediated drug interactions based on clinical dataImpact of genetic polymorphism on drug-drug interactions mediated by cytochromes: a general approach.Characterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: implications in warfarin therapy.Current clinical evidence on pioglitazone pharmacogenomics.How Informative Are Drug-Drug Interactions of Gene-Drug Interactions?Quantitative Prediction of Drug Interactions Caused by CYP1A2 Inhibitors and Inducers.Physiologically Based Pharmacokinetic Modelling of Cytochrome P450 2C9-Related Tolbutamide Drug Interactions with Sulfaphenazole and Tasisulam.Semi-Mechanistic Model for Predicting the Dosing Rate in Children and Neonates for Drugs Mainly Eliminated by Cytochrome Metabolism.Modeling Drug Disposition and Drug-Drug Interactions Through Hypothesis-Driven Physiologically Based Pharmacokinetics: a Reversal Translation Perspective.
P2860
Q28544111-4DCC9615-B5C4-4B1D-9171-93CC6C89C8BEQ30856965-453420DC-52D4-489D-AD44-D21840586A22Q37207816-A04AD95A-16BA-4219-A387-A65D35B92E09Q37325594-A36A3658-6A3E-4E2B-937F-218CDB1EF898Q37342358-67AFB70F-5771-449F-A948-0CE87B06C1BAQ39867480-271F2137-13FB-498B-A0B2-6331E898F85CQ39952865-38969612-0956-4574-98E7-EE161B2999C3Q47628234-8212D994-2C9B-4FAA-B8BD-517B64A7D3A6Q47826980-D7D3126C-C967-4DC8-9DD9-8583AEADDB12Q50076374-9745BB4D-22E3-4DC5-B514-606CFC70E954
P2860
Quantitative prediction of the impact of drug interactions and genetic polymorphisms on cytochrome P450 2C9 substrate exposure.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Quantitative prediction of the ...... e P450 2C9 substrate exposure.
@en
Quantitative prediction of the ...... e P450 2C9 substrate exposure.
@nl
type
label
Quantitative prediction of the ...... e P450 2C9 substrate exposure.
@en
Quantitative prediction of the ...... e P450 2C9 substrate exposure.
@nl
prefLabel
Quantitative prediction of the ...... e P450 2C9 substrate exposure.
@en
Quantitative prediction of the ...... e P450 2C9 substrate exposure.
@nl
P2093
P2860
P1476
Quantitative prediction of the ...... e P450 2C9 substrate exposure.
@en
P2093
Anne-Charlotte Castellan
Behrouz Kassaï
François Gueyffier
Fredéric Cambriels
Genophar Working Group
Michel Tod
Mélanie Audars
Patrice Nony
P2860
P2888
P304
P356
10.1007/S40262-013-0031-3
P577
2013-03-01T00:00:00Z
P6179
1045255829